original ) (raw )Efficacy of Oral Ribavirin in Lung Transplant Patients With Respiratory Syncytial Virus Lower Respiratory Tract Infection
Andres Pelaez
Journal of Heart and Lung Transplantation, 2009
View PDFchevron_right
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections
Shashank Ghantoji
Journal of Antimicrobial Chemotherapy, 2013
View PDFchevron_right
Randomized Controlled Multicenter Trial of Aerosolized Ribavirin for Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic Cell Transplant Recipients
Humberto Fernandez
Clinical Infectious Diseases, 2007
View PDFchevron_right
Successful Treatment of Respiratory Syncytial Virus Infection in an Immunocompromised Patient With Ribavirin
Dhan Shrestha
Cureus, 2021
View PDFchevron_right
Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin
Cindy Ippoliti
Bone Marrow Transplantation, 2000
View PDFchevron_right
Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
Amrita Prayag
Clinical Infectious Diseases, 2018
View PDFchevron_right
Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience
John Gribben
British Journal of Haematology, 2009
View PDFchevron_right
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections
Jan Andersson
Bone Marrow Transplantation, 1997
View PDFchevron_right
Respiratory Syncytial Virus Infection in Patients with Hematological Diseases: Single-Center Study and Review of the Literature
Hans Hirsch
Clinical Infectious Diseases, 2008
View PDFchevron_right
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract
Kathleen Mullane
Clinical Infectious Diseases
View PDFchevron_right
Intravenous Ribavirin Therapy for Adenovirus Gastroenteritis After Bone Marrow Transplantation
Hayley Altman Gans
Journal of Pediatric Gastroenterology and Nutrition, 1995
View PDFchevron_right
The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management
Tahsine Mahfouz
Blood, 2004
View PDFchevron_right
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract
Kathleen Mullane
Clinical Infectious Diseases, 2019
View PDFchevron_right
Respiratory syncytial virus and other respiratory viruses in the setting of bone marrow transplantation
Robert Welliver
Current Opinion in Oncology, 2009
View PDFchevron_right
Management of Infections Caused by Respiratory Syncytial Virus
Jan Andersson , Lars Navér
Scandinavian Journal of Infectious Diseases, 2001
View PDFchevron_right
Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study
Suparno Chakrabarti
Bone Marrow Transplantation, 2001
View PDFchevron_right
Respiratory syncytial virus infection among adults after hematopoietic stem cell transplantation
Jyoti Jethani
Journal of Global Infectious Diseases, 2022
View PDFchevron_right
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
Silvy Lachance
Clinical Infectious Diseases, 2019
View PDFchevron_right
Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review
Faris Bakri
Bone Marrow Transplantation, 2001
View PDFchevron_right
RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus
Martin Zamora
American Journal of Respiratory and Critical Care Medicine, 2011
View PDFchevron_right
Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy
Suparno Chakrabarti
Bone Marrow Transplantation, 1999
View PDFchevron_right
Management of respiratory viral infections in hematopoietic cell transplant recipients
Shashank Ghantoji
American journal of blood research, 2012
View PDFchevron_right
Respiratory Syncytial Virus in Blood and Marrow Transplant Recipients
Brenda Shelton
Clinical Journal of Oncology Nursing, 2003
View PDFchevron_right
Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy
Jesica Paola
Journal of Heart and Lung Transplantation, 2010
View PDFchevron_right
Infection With Novel Respiratory Syncytial Virus Genotype Ontario (ON1) in Adult Hematopoietic Cell Transplant Recipients, Texas, 2011-2013
Jacques Azzi
Journal of Infectious Diseases, 2014
View PDFchevron_right
Antiviral therapy of respiratory viruses in haematopoietic stem cell transplant recipients
Christian Renaud
Antiviral Therapy, 2012
View PDFchevron_right
Intravenous Ribavirin Treatment for Severe Adenovirus Disease in Immunocompromised Children
Ben Katz
Pediatrics, 2002
View PDFchevron_right
Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease
Jane Kuypers
Journal of Infectious Diseases, 2014
View PDFchevron_right
Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections
Tobias Welte
Antiviral Therapy, 2011
View PDFchevron_right
Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Patricia Ribaud
Bone Marrow Transplantation, 2003
View PDFchevron_right
A Phase 2b Randomized Controlled Trial of Presatovir, an Oral RSV Fusion Inhibitor, for the Treatment of Respiratory Syncytial Virus (RSV) in Lung Transplant (LT) Recipients
Daniel Dilling
Journal of Heart and Lung Transplantation, 2018
View PDFchevron_right
Respiratory syncytial virus infection outbreak among pediatric patients with oncologic diseases and/or BMT
Didem Öztürk
Pediatric Pulmonology, 2010
View PDFchevron_right